Lots of studies have provided evidences: elevated levels of several inflammatory markers such as C‐reactive protein (CRP) (Wen et al., 2008), interleukin 6 (IL‐6) (Che, Liu, Wang et al., 2014), and IL1receptor antagonist (IL1Ra) significantly increased the risk of endometrial cancer (Yu et al., 2016). The gene discussed is IL6; the disease is endometrial cancer.